| Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia J Li, DE Van Der Wal, G Zhu, M Xu, I Yougbare, L Ma, B Vadasz, N Carrim, ... Nature communications 6 (1), 7737, 2015 | 359 | 2015 |
| CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis H Yang, Q Zhang, M Xu, L Wang, X Chen, Y Feng, Y Li, X Zhang, W Cui, ... Molecular Cancer 19, 1-14, 2020 | 247 | 2020 |
| Genome sequencing analysis identifies Epstein–Barr virus subtypes associated with high risk of nasopharyngeal carcinoma M Xu, Y Yao, H Chen, S Zhang, SM Cao, Z Zhang, B Luo, Z Liu, Z Li, ... Nature genetics 51 (7), 1131-1136, 2019 | 156 | 2019 |
| Vasculogenic mimicry formation in EBV-associated epithelial malignancies T Xiang, YX Lin, W Ma, HJ Zhang, KM Chen, GP He, X Zhang, M Xu, ... Nature communications 9 (1), 5009, 2018 | 138 | 2018 |
| A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP H Zhou, M Xu, P Qin, H Zhang, C Yuan, H Zhao, Z Cui, Y Meng, L Wang, ... Blood, The Journal of the American Society of Hematology 125 (10), 1541-1547, 2015 | 118 | 2015 |
| Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis XR Xu, Y Wang, R Adili, L Ju, CM Spring, JW Jin, H Yang, MAD Neves, ... Nature communications 9 (1), 3608, 2018 | 90 | 2018 |
| GPIbα is required for platelet-mediated hepatic thrombopoietin generation M Xu, J Li, MAD Neves, G Zhu, N Carrim, R Yu, S Gupta, J Marshall, ... Blood, The Journal of the American Society of Hematology 132 (6), 622-634, 2018 | 75 | 2018 |
| Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia L Tao, Q Zeng, J Li, M Xu, J Wang, Y Pan, H Wang, Q Tao, Y Chen, ... Journal of hematology & oncology 10, 1-4, 2017 | 71 | 2017 |
| CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia L Ma, E Simpson, J Li, M Xuan, M Xu, L Baker, Y Shi, I Yougbaré, X Wang, ... Blood, The Journal of the American Society of Hematology 126 (2), 247-256, 2015 | 71 | 2015 |
| Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies M Xu, WL Zhang, Q Zhu, S Zhang, Y Yao, T Xiang, QS Feng, Z Zhang, ... Theranostics 9 (4), 1115, 2019 | 68 | 2019 |
| High‐dose dexamethasone or all‐trans‐retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia Q Feng, M Xu, YY Yu, Y Hou, X Mi, YX Sun, S Ma, XY Zuo, LL Shao, ... Journal of Thrombosis and Haemostasis 15 (9), 1845-1858, 2017 | 67 | 2017 |
| The integrin PSI domain has an endogenous thiol isomerase function and is a novel target for antiplatelet therapy G Zhu, Q Zhang, EC Reddy, N Carrim, Y Chen, XR Xu, M Xu, Y Wang, ... Blood, The Journal of the American Society of Hematology 129 (13), 1840-1854, 2017 | 66 | 2017 |
| Arachidonic acid metabolism controls macrophage alternative activation through regulating oxidative phosphorylation in PPARγ dependent manner M Xu, X Wang, Y Li, X Geng, X Jia, L Zhang, H Yang Frontiers in Immunology 12, 618501, 2021 | 61 | 2021 |
| High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia Y Hou, Q Feng, M Xu, G Li, X Liu, Z Sheng, H Zhou, J Ma, Y Wei, Y Sun, ... Blood, The Journal of the American Society of Hematology 127 (12), 1587-1597, 2016 | 61 | 2016 |
| Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial L Sun, J Wang, L Shao, C Yuan, H Zhao, D Li, Z Wang, P Han, Y Yu, M Xu, ... The Lancet Haematology 8 (4), e289-e298, 2021 | 42 | 2021 |
| NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway C Zhong, R Wang, M Hua, C Zhang, F Han, M Xu, X Yang, G Li, X Hu, ... Frontiers in Immunology 12, 661939, 2021 | 31 | 2021 |
| Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia J Ma, Y Ning, M Xu, Y Hou, N Wang, X Hou, Y Yu, H Li, W He, L Shao, ... Blood, The Journal of the American Society of Hematology 122 (12), 2074-2082, 2013 | 27 | 2013 |
| Hepatotoxicity study of combined exposure of DEHP and ethanol: A comprehensive analysis of transcriptomics and metabolomics Y Li, Q Zhang, J Fang, N Ma, X Geng, M Xu, H Yang, X Jia Food and chemical toxicology 141, 111370, 2020 | 26 | 2020 |
| Tocopherols inhibit esophageal carcinogenesis through attenuating NF-κB activation and CXCR3-mediated inflammation H Yang, M Xu, F Lu, Q Zhang, Y Feng, CS Yang, N Li, X Jia Oncogene 37 (29), 3909-3923, 2018 | 21 | 2018 |
| Imbalance between CD205 and CD80/CD86 in dendritic cells in patients with immune thrombocytopenia XL Zhang, J Ma, M Xu, F Meng, M Qu, J Sun, P Qin, L Wang, Y Hou, ... Thrombosis research 135 (2), 352-361, 2015 | 17 | 2015 |
Heyu NiScientist, Canadian Blood Services & St. Michael's Hospital; Professor, University of TorontoVerified email at smh.ca
